Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
CHATTANOOGA, Tenn., Nov. 9 /PRNewswire-FirstCall/ -- Miller Industries, Inc. (NYSE:MLR) (the "Company") today announced financial results for the third quarter ended September 30, 2009. For the...
RNS Number:8109S Maelor PLC 22 April 2008 22 April 2008 Maelor plc ("Maelor" or the "Company") Director dealings On 22 April 2008 the Company received notification of the following...
RNS Number:8107S Maelor PLC 22 April 2008 22 April 2008 Maelor plc ( 'Maelor' or the 'Company') Consolidation and Placing The Board of Maelor plc (AIM:MLR), the...
RNS Number:7668S Maelor PLC 21 April 2008 21 April 2008 Maelor plc ('Maelor' or the 'Company') Result of General Meeting The Board of Maelor plc (AIM:MLR), the specialist hospital...
RNS Number:9888Q Maelor PLC 28 March 2008 28 March 2008 Maelor plc ('Maelor' or the 'Company') Acquisition of Speciality European Pharma International AG The Board of...
RNS Number:6841N Maelor PLC 11 February 2008 11th February 2008 Maelor plc ("Maelor" or the "Company") Maelor Launches Aloxi(R) (palonosetron) in the UK MAELOR PLC (AIM:MLR), the...
RNS Number:7013J Maelor PLC 11 December 2007 Maelor plc 11 December 2007 Maelor plc (the 'Company' or 'Maelor') Notification of Interest The Company was...
RNS Number:1113H Maelor PLC 06 November 2007 06 November 2007 Maelor plc ("Maelor" or the "Company") Director dealings The Company was informed on 6 November 2007...
RNS Number:0758H Maelor PLC 06 November 2007 6th November 2007 Maelor plc (the 'Company' or the 'Group') - Interim Results Maelor transformed to deliver profits ahead of expectations...
RNS Number:5093G Maelor PLC 29 October 2007 Maelor plc 29 October 2007 Maelor plc MAELOR and HELSINN ANNOUNCE A LICENSE AGREEMENT FOR ALOXI(R) (PALONOSETRON) IN THE...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
